ATOS · Company research
Atossa Therapeutics, Inc. Common Stock (ATOS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Atos Group Share: -58% Over One Year, Stock Falls Another 2% - Idéal Investisseur | Atos Group Share: -58% Over One Year, Stock Falls Another 2% Idéal Investisseur | View source ↗ | Idéal Investisseur | Oct 15, 2026 | neutral | 0 | 0.6 |
| Up to $50 million could go to Atossa shareholders if it sells or uses its first qualifying FDA drug-review voucher. - Stock Titan | Up to $50 million could go to Atossa shareholders if it sells or uses its first qualifying FDA drug-review voucher. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Top of the SBF 120: Atos Group stock climbs 3.5% against short sellers - Ideal Investisseur | Top of the SBF 120: Atos Group stock climbs 3.5% against short sellers Ideal Investisseur | View source ↗ | Ideal Investisseur | Oct 9, 2026 | neutral | 0 | 0.6 |
| Atos Group Share: -37% over the quarter, and the stock continues to slide during the session - Ideal Investisseur | Atos Group Share: -37% over the quarter, and the stock continues to slide during the session Ideal Investisseur | View source ↗ | Ideal Investisseur | Oct 8, 2026 | neutral | 0 | 0.6 |
| Atos Group (ATO.PA) Stock Price, News, Quote & History - Yahoo! Finance Canada | Atos Group (ATO.PA) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| Atos Group (ATO.PA) stock price, news, quote and history - Yahoo Finance Australia | Atos Group (ATO.PA) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 5, 2026 | neutral | 0 | 0.6 |
| Atos Group (ATOP.XC) Stock Price, News, Quote & History - Yahoo! Finance Canada | Atos Group (ATOP.XC) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Sep 30, 2026 | neutral | 0 | 0.6 |
| Atossa Plans $50M-Capped CVR for Voucher Proceeds | ATOS Stock News - Stock Titan | Atossa Plans $50M-Capped CVR for Voucher Proceeds | ATOS Stock News Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Atos H1 2026 slides show margin gains, but shares sink 31% on growth - Investing.com | Atos H1 2026 slides show margin gains, but shares sink 31% on growth Investing.com | View source ↗ | Investing.com | Jul 30, 2026 | neutral | 0 | 0.6 |
| Atos Group (ENXTPA:ATO) - Stock Analysis - Simply Wall Street | Atos Group (ENXTPA:ATO) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Jun 24, 2026 | neutral | 0 | 0.6 |
| Atos Group Stock (ATO) - Quote Euronext Paris - marketscreener.com | Atos Group Stock (ATO) - Quote Euronext Paris marketscreener.com | View source ↗ | marketscreener.com | Jun 20, 2026 | neutral | 0 | 0.6 |
| Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds - PR Newswire | Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds PR Newswire | View source ↗ | PR Newswire | Jun 11, 2026 | neutral | 0 | 0.6 |
| Atossa Therapeutics stock tumbles on $4.5M stock offering - Investing.com | Atossa Therapeutics stock tumbles on $4.5M stock offering Investing.com | View source ↗ | Investing.com | Jun 11, 2026 | neutral | 0 | 0.6 |
| Atossa Therapeutics Prices Registered Direct Offering at $3.30, Netting About $4.1 Million - TradingView | Atossa Therapeutics Prices Registered Direct Offering at $3.30, Netting About $4.1 Million TradingView | View source ↗ | TradingView | Jun 11, 2026 | neutral | 0 | 0.6 |
| ATOS Stock Drops After Hours On Earnings Miss — CEO Now Bets On New Uses For Its Experimental Cancer Drug - Stocktwits | ATOS Stock Drops After Hours On Earnings Miss — CEO Now Bets On New Uses For Its Experimental Cancer Drug Stocktwits | View source ↗ | Stocktwits | Mar 25, 2026 | neutral | 0 | 0.6 |
| Atos Stock Forecast | Sovereign Cloud, AI Expansion - Capital.com | Atos Stock Forecast | Sovereign Cloud, AI Expansion Capital.com | View source ↗ | Capital.com | Jan 27, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.